Particle.news
Download on the App Store
33 ARTICLES
·
2w ago

NHS Empowers GPs to Prescribe Mounjaro for Severe Obesity

Targeting patients with a BMI above 40 plus multiple obesity-related conditions, the rollout prompts warnings that GP capacity is insufficient; integrated lifestyle services are essential.

Image
Image
Image

Overview

  • The NHS began GP prescribing of Mounjaro across England on June 23 as part of a three-year mass rollout.
  • Around 220,000 people deemed to have the “greatest need” will be eligible for the weekly injection over the next three years.
  • Eligibility is limited to patients with a BMI above 40 and at least four obesity-related health conditions.
  • The antidiabetic jab lowers blood sugar, slows digestion and increases satiety to drive weight loss but may cause nausea, diarrhoea and constipation and is not recommended for pregnant or breastfeeding women.
  • GP leaders warn that without extra training and resources the added workload could strain practices, and pharmacy experts stress that sustained results require comprehensive lifestyle coaching, nutritional guidance and ongoing support.